OP 352
Alternative Names: G-protein coupled receptor modulator - Pfizer/Outpost Medicine; GPCR modulator - Pfizer/Outpost Medicine; OP-352Latest Information Update: 28 Nov 2022
At a glance
- Originator Arena Pharmaceuticals
- Developer Outpost Medicine; Pfizer
- Class Small molecules; Urologics
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Faecal incontinence; Urinary-Stress-Incontinence
Most Recent Events
- 28 Nov 2022 No recent reports of development identified for phase-I development in Faecal-Incontinence in USA
- 28 Nov 2022 No recent reports of development identified for phase-I development in Stress-incontinence in USA
- 11 Mar 2022 Arena Pharmaceuticals has been acquired and merged into Pfizer